Skip to main content
Log in

Octreotide versus terlypressin in acute variceal hemorrhage in liver cirrhosis Emergency control and prevention of early rebleeding

  • Original Article
  • Published:
The clinical investigator Aims and scope Submit manuscript

Abstract

Sixty patients with endoscopically confirmed active variceal bleeding entered a randomized controlled clinical trial aimed at comparing the efficacy of octreotide vs. terlypressin in the control of acute variceal hemorrhage (period I, 24 h) and in the prevention of early rebleeding (period II, 6 days). Of the sixty 30 received octreotide (period I, 100 μg bolus followed by continuous intravenous infusion at 25 μg/h; period IT, 100 μg t.i.d. subcutaneously), and 30 received terlypressin (period I, 2 mg intravenous bolus every 4 h; period II, 2nd day, 2 mg every 6 h; from 3th to 7th days, 1 mg every 6 h). Control of bleeding was achieved in 23 (76.6%) patients receiving octreotide and in 16 (53%) treated with terlypressin (NS); none of these patients suffered rebleeding during treatment. No significant difference in mortality was observed between the two groups during the hospitalization period. Complications due to therapy were lower with octreotide than with terlypressin (P < 0.01). Under the same effectiveness conditions the cost/benefit ratio must be taken into account.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Beppu K, Inokuchi K, Koyanagi N, Nakayama S, Sakata H, Kitano S, Kobayashi M (1981) Prediction of variceal hemorrhage by esophageal endoscopy. Gastrointest Endosc 27:213–218

    Google Scholar 

  2. Bosch J, Kravetz D, Rodes J (1981) Effects of somatostatin on hepatic and systemic hemodynamics in patients with cirrhosis of the liver. Comparison with vasopressin. Gastroenterology 80:518–525

    Google Scholar 

  3. Burroughs AK, McCormick PA, Spangers D, McIntyre N (1989) Randomized double-blind placebo controlled study of somatostatin for control of variceal bleeding. Gut 29: A1431

    Google Scholar 

  4. Burroughs AK, McCormick PA, Hughes MD, Spangers D, D'Heygere F, McIntyre N (1990) Randomized, double-blind, placebo-controlled trial of somatostatin for variceal bleeding. Gastroenterology 99:1388–1394

    Google Scholar 

  5. Christiansen J, Ottenjann R, Von Arx F (1989) Placebo-controlled trial with the somatostatin analogue SMS 201–995 in peptic ulcer. Gastroenterology 97:568–574

    Google Scholar 

  6. Conn HO, Ransby GR, Storer EH, Mutchnick MG, Joshi PH, Phillips MM, Cohen GA, Fields GN, Petroski D (1975) Intrarterial vasopressin in the treatment of upper gastrointestinal hemorrhage: a prospective controlled clinical trial. Gastroenterology 68:211–221

    Google Scholar 

  7. Conn HO (1981) A peek at the Child-Turcotte classification. Hepatology 1:673–676

    Google Scholar 

  8. Fiaccadori F, Pedretti G, Biraghi M, Arcidiacono R (1993) Terlypressin and endoscopic sclerotherapy control variceal bleeding and prevent early rebleeding in cirrhotic patients. Curr Ther Res 54:519–528

    Google Scholar 

  9. Del Pozo E, Neufeld M, Schluter K, Tortosa F, Clarenbach P (1986) Endocrine profile of a long-acting somatostatin derivate SMS 201–995: study in normal volunteers following subcutaneous administration. Acta Endocrinol 111:433–439

    Google Scholar 

  10. Freeman JG, Cobden I, Lishman AH, Record CO (1982) Controlled trial of terlypressin (glypressin) versus vasopressin in the early treatment of oesophageal varices. Lancet II: 66–68

    Google Scholar 

  11. Freeman JG, Cobden I, Record CO (1989) Placebo controlled trial of terlypressin (glypressin) in the management of acute variceal bleeding. J Clin Gastroenterol 11:58–60

    Google Scholar 

  12. Jenkins SA, Baxter JN, Corbett W, Dewitt P, Ware J, Shields R (1985) A prospective randomized controlled clinical trial comparing somatostatin and vasopressin in controlling acute variceal hemorrhage. Br Med J 290:275–278

    Google Scholar 

  13. Jenkins SA, Baxter JN, Corbett WA, Shields R (1985) The effects of somatostatin analogue SMS 201–995 on hepatic hemodynamics in the cirrhotic rat. Br J Surg 72:864–867

    Google Scholar 

  14. Jenkins SA, Baxter JN, Ellenbogen S, Shields R (1988) Effects of somatostatin and SMS 201–995 on hepatic and systemic hemodynamics in patients with cirrhosis and portal hypertension. Gut 29: A 720

    Google Scholar 

  15. Kravetz D, Bosch J, Teres J, Bruix J, Rimola A, Rodes J (1984) Comparison of intravenous somatostatin and vasopressin infusion in the treatment of acute variceal hemorrhage. Hepatology 4:442–446

    Google Scholar 

  16. Lin HC, Tsai YT, Lee FY, Lee SD, Hsia HC, Lin WJ, Lo KJ (1992) Hemodynamic evaluation of octreotide in patients with hepatitis B-related cirrhosis. Gastroenterology 103:229–234

    Google Scholar 

  17. McKee R (1990) A study of octreotide in oesophageal varices. Digestion 45 [Suppl 1]:60–65

    Google Scholar 

  18. Merigan TC Jr, Plotkin GR, Davidson CS (1962) Effect on intravenously administered posterior pituitary extract of hemorrhage from bleeding esophageal varices. A controlled evaluation. N Engl J Med 266:134–135

    Google Scholar 

  19. Navasa M, Bosch J, Chesta J, Bru C, Pizcueta P, Garcia-Pagan JC, Betz C, Casamitjana R, Rodes J (1988) Hemodynamic effects of subcutaneous administration of SMS 201–995, a long acting somatostatin analogue, in patients with cirrhosis and portal hypertension. J Hepatol 7: S64

    Google Scholar 

  20. Olsson R (1980) The natural hystory of esophageal varices: a retrospective study of 224 cases with liver cirrhosis. Digestion 6:65–74

    Google Scholar 

  21. Pliska V, Chard T, Rudinger J, Forsling ML (1976) In vivo activation of synthetic hormonogens of lysine-vasopressin: N-glycyl-glycyl-glycyl-(8-lysine)vasopressin in the cat. Acta Endocrinol 81:474–481

    Google Scholar 

  22. Pugh RN, Munnay Lyon IM, Dawson JL, Pietroni MC, Williams R (1973) Transection of the oesophagus for bleeding esophageal varices. Br J Surg 60:646–649

    CAS  PubMed  Google Scholar 

  23. Rabol A, Juhl E, Schmidt A, Winkler K (1976) The effect of vasopressin and tryglycyl lysine vasopressin (terlypressin) on the splanchnic in cirrhotic patients with portal hypertension. Digestion 14:285–289

    Google Scholar 

  24. Shaldon S, Sherlock S (1960) The use of vasopressin (pitressine) in the control of bleeding from esophageal varices. Lancet II: 222–225

    Google Scholar 

  25. Shaldon S, Dolle W, Guevara L, Iber FL, Sherlok S (1961) Effect of pitressin on the splanchnic circulation in man. Circulation 24:797–807

    Google Scholar 

  26. Silvain C, Carpentier S, Sautereau S, Sautereau D, Czernichow B, Metreau JM, Fort E, Ingrand P, Boyer J, Pillegand B, Doffel M, Dhumeaux D, Beauchant M (1993) Terlypressin plus transdermal nitroglycerin vs. octreotide in the control of acute bleeding from esophageal varices: a multicenter randomized trial. Hepatology 18:61–65

    Google Scholar 

  27. Soderlund C, Magnusson I, Tongfen S, Lundell L (1990) Terlypressin controls acute bleeding oesophageal varices: a double-blind, randomised placebo-controlled trial. Scand J Gastroenterol 25:622–630

    Google Scholar 

  28. Sung JJY, Chung SCS, Lai CW, Chan FKL, Leung JWC, Yung MY, Kassianides C, Li AKC (1993) Octreotide infusion or emergency sclerotherapy for variceal hemorrhage. Lancet 342:637–641

    Google Scholar 

  29. Terblanche J, Burroughs AK, Hobbs KEF (1989) Controversies in the management of bleeding esophageal varices. N Engl J Med 320:1393–1398

    Google Scholar 

  30. Testoni PA, Masci E, Passaretti A (1986) Comparison of somatostatin and cimetidine in the treatment of acute bleeding esophageal varices. Curr Ther Res 39:758–761

    Google Scholar 

  31. The North Italian Endoscopic Club (1987) Protocolli di valutazione endoscopica, definizioni acquisite e proposta di nuove definizioni. Procedings, I Convegno Nazionale NIEC 1984

  32. Vosmik J, Jedlicka K, Muldler J, Cort JH (1977) Action of triglycyl hormonogen of vasopressin (glypressin) in patients with liver cirrhosis and bleeding esophageal varices. Gastroenterology 72:605–609

    Google Scholar 

  33. Walker S, Stiehl A, Reedsch R, Kommerell B (1986) Terlypressin in bleeding oesophageal varices: a placebo controlled, double-blind study. Hepatology 6:112–115

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Correspondence to: F. Fiaccadori

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pedretti, G., Elia, G., Calzetti, C. et al. Octreotide versus terlypressin in acute variceal hemorrhage in liver cirrhosis Emergency control and prevention of early rebleeding. Clin Investig 72, 653–659 (1994). https://doi.org/10.1007/BF00212982

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00212982

Key words

Navigation